Outcome of kidney transplantation from high-risk donors is determined by both structure and function

被引:186
作者
Karpinski, J [1 ]
Lajoie, G [1 ]
Cattran, D [1 ]
Fenton, S [1 ]
Zaltzman, J [1 ]
Cardella, C [1 ]
Cole, E [1 ]
机构
[1] Univ Toronto, Renal Transplantat Program, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1097/00007890-199904270-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Method. Despite the need to expand the donor pool, it is unclear what; parameters should be used, The value of donor renal pathology and calculated creatinine clearance (CrCl) in determining recipient outcome was assessed in 57 kidney transplants from 34 donors in whom pretransplant renal biopsies were performed because of age greater than or equal to 60, hypertension, and/or vascular disease. me retrospectively compared clinical outcomes in these recipients and 57 control recipients selected to have the same baseline demographics but receiving transplants from low risk donors who were significantly younger (32+/-13.9 vs. 61+/-7.3 years) and lighter weight (71+/-18.1 vs. 84+/-20.2 kg) than the high-risk donors (P<.001 for both). Results. Recipients of high-risk kidneys had a higher incidence of delayed graft function, defined by a <10% fall in serum creatinine (Cr) in the first 24 hr, (56% vs, 30%, P<.01), a higher incidence of rejection (60% vs. 37%, P=.02) and a higher Cr level (197+/-64 vs. 144+/-54 mu mol/L at 18 months, P<.005). Graft and patient survival were similar; 12% and 5% vs, 9% and 9% in highrisk vs. control groups, respectively (P=NS). Donor renal pathology was scored 0-3 (none to severe disease) in four areas: glomerulosclerosis, interstitial fibrosis, tubular atrophy, and vascular disease. A donor vessel score of 3/3 was associated with a 100% incidence of delayed graft function and a mean 1-year Cr level of 275+/-106 mu mol/L (compared with 43% and 192+/-54 mu mol/L in those with lower vessel scores, P<.05). Calculated donor CrCl <100 ml/min was associated with higher recipient Cr levels at 1 year, 240+/-95 mu mol/L vs. 180+/-54 mu mol/L in recipients of kidneys from donors with CrCl levels >100 ml/min (P<.05). The mean 1-year Cr level was 320+/-102 mu mol/L in recipients with both a vascular score of 3/3 and a donor CrCl<100 ml/min and 184+/-63 mu mol/L in those with neither factor (P=.001). Conclusion. Calculated donor CrCl and donor vascular pathology predict recipient graft function and may be helpful in selecting high-risk donors for single kidney transplantation.
引用
收藏
页码:1162 / 1167
页数:6
相关论文
共 34 条
  • [1] EFFECT OF DONOR AGE ON OUTCOME OF KIDNEY-TRANSPLANTATION - A 2-YEAR ANALYSIS OF TRANSPLANTS REPORTED TO THE UNITED-NETWORK-FOR-ORGAN-SHARING-REGISTRY
    ALEXANDER, JW
    BENNETT, LE
    BREEN, TJ
    [J]. TRANSPLANTATION, 1994, 57 (06) : 871 - 876
  • [2] ALEXANDER JW, 1992, EXPANDED DONOR CRITE
  • [3] When should expanded criteria donor kidneys be used for single versus dual kidney transplants?
    Alfrey, EJ
    Lee, CM
    Scandling, JD
    Pavlakis, M
    Markezich, AJ
    Dafoe, DC
    [J]. TRANSPLANTATION, 1997, 64 (08) : 1142 - 1146
  • [4] THE OLDER LIVING RENAL DONOR - PROGNOSIS FOR THE DONOR AND RECIPIENT
    ASKARI, A
    NOVICK, AC
    BRAUN, WE
    STEINMULLER, D
    [J]. JOURNAL OF UROLOGY, 1980, 124 (06) : 779 - 780
  • [5] AGING AND THE KIDNEY
    BROWN, WW
    DAVIS, BB
    SPRY, LA
    WONGSURAWAT, N
    MALONE, JD
    DOMOTO, DT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (09) : 1790 - 1796
  • [6] IMPROVEMENT OF KIDNEY-TRANSPLANT REGRAFT RESULTS BY USING TRAUMA DEATH DONORS
    CECKA, JM
    TERASAKI, PI
    [J]. TRANSPLANTATION, 1987, 44 (06) : 792 - 795
  • [7] CECKA JM, 1997, CLIN TRANSPLANTS 199
  • [8] Antigen-independent determinants of cadaveric kidney transplant failure
    Chertow, GM
    Milford, EL
    Mackenzie, HS
    Brenner, BM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21): : 1732 - 1736
  • [9] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [10] COLE E, 1995, CLIN TRANSPLANT, V9, P282